Differential (Click to cross reference) adverse drug reaction aggression agitation algorithm Alzheimer's disease Alzheimer's disease, behavioral symptoms Alzheimer's disease, treatment of anticholinesterase antidepressant antioxidant anxiety attention deficit disorder with hyperactivity atypical behavior behavior, combative behavioral disorder black box warning bromide carbamazepine caregiver cerebrovascular accident clonidine clozapine comorbidities confusion confusional state, acute creatine phosphokinase(CPK)elevated dantrolene sodium delirium delirium, work up for delusion dementia dementia, prevention of dementia, treatment of depression donepezil drug interactions echolalia efficacy encephalopathy enzyme inhibition epidemiology of neurology evidence-based research fever fibrinolytic agents, utilization fluoxetine Gilles de la Tourette syndrome grunting haloperidol hoarding iatrogenic neurologic disorders inappropriate behavior lethargy medication withdrawal memantine methylphenidate metrifonate misdiagnosis mortality movement disorder movement disorder, drug induced movement disorder, extrapyramidal myelomeningocele neuroleptic neuroleptic malignant syndrome neuroleptic, atypical neurologic disease, diagnoses of neurologic disease, diagnoses of, clinical bedside neurological intensive care nonsteroidal anti-inflammatory drug nursing home obsessive-compulsive disorder olanzapine old age, neurology of palilalia Parkinson disease Parkinson disease, drug induced Parkinson disease, exacerbation Parkinsonism syndrome placebo postoperative neurologic complications prevention of neurologic disorders psychiatric problems in neurologic disorders psychomotor retardation psychosis psychotic behavior quality of life quetiapine recurrent repetitive questioning review article rigidity risk factors risk-benefit assessment risperidone rummaging safety selective serotonin reuptake inhibitors shadowing sleep sleep pathology and physiology sniffing stereotyped behavior stimulant drugs throat-clearing tic tic, motor tic, vocal treatment of neurologic disorder treatment, non-pharmacologic wandering weight gain

Showing articles 0 to 15 of 15 Diagnosis and Treatment of Tourette Syndrome Neurol 87:e65-e67, Hirschtritt, M.E.,et al, 2016 Assessment and Management of Behavioral and Psychological Symptoms of Dementia BMJ 350:h369, Kales, H.C.,et al, 2015 Relapse Risk after Discontinuation of Risperidone in Alzheimers Disease NEJM 367:1497-1507, Devanand, D.P.,et al, 2012 Risperidone, Haloperidol, and Placebo in the Treatment of Aggressive Challenging Behaviour in Patients With Intellectual Disability: A Randomised Controlled Trial Lancet 371:57-63,9, Tyrer,P.,et al, 2008 Delirium in Older Persons NEJM 354:1157-1165, Inouye,S.K., 2006 Atypical Antipsychotics in the Elderly with Parkinson Disease and the "Black Box" Warning Neurol 67:564-566, Friedman,J.H., 2006 Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimers Disease NEJM 355:1525-1538,1604, Schneider,L.S.,et al, 2006 Pharmacological treatment of Neuropsychiatric Symptoms of Dementia JAMA 293:596-608, Sink,K.M.,et al, 2005 Psychiatric Emergencies, The Neuroleptic Malignant and Serotonin Syndromes Emerg Med Clin North Am 18:317-325, Carbone,J.R., 2000 Neurologic Side Effects in Neuroleptic-Naive Patients Treated with Haloperidol or Risperidone Neurol 52:782-785, Rosebush,P.I.&Mazurek,M.F., 1999 A Randomized Trial of Risperidone,Placebo,and Haloperidol for Behavioral Symptoms of Dementia Neurol 53:946-955,899, DeDeyn,P.P.,et al, 1999 Treatment of Alzheimer's Disease NEJM 341:1670-1679, Mayeux,R.&Sano,M, 1999 Extrapyramidal Side Effects with Low-Dose Risperidone Can J Psychiatry 42:325-325, Brown, E.S., 1997 Resperidone in Gilles de la Tourette Syndrome Neurol 45:1419, Shulman,L.M.,et al, 1995 Risperidone Lancet 343:457-460, Livingston,M.G., 1994 Showing articles 0 to 15 of 15